Pfizer And EpiPen Consumers Reach $345M Deal
By J. Edward Moreno · July 15, 2021, 6:29 PM EDT
Pfizer has reached a $345 million settlement with a class of consumers who allege they overpaid for EpiPens because of anti-competitive practices by pharmaceutical companies, potentially clearing the company from having...
To view the full article, register now.